[go: up one dir, main page]

AU2002212659A1 - Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof - Google Patents

Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof

Info

Publication number
AU2002212659A1
AU2002212659A1 AU2002212659A AU1265902A AU2002212659A1 AU 2002212659 A1 AU2002212659 A1 AU 2002212659A1 AU 2002212659 A AU2002212659 A AU 2002212659A AU 1265902 A AU1265902 A AU 1265902A AU 2002212659 A1 AU2002212659 A1 AU 2002212659A1
Authority
AU
Australia
Prior art keywords
zafirlukast
manufacture
pharmaceutical compositions
solvate form
crystalline ethanolate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212659A
Inventor
Arie Gutman
Gennady Nisnevich
Boris Pertsikov
Victor Ponomarev
Maxim Sotrihin
Igor Zaltzman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Finetech Ltd
Original Assignee
ISP FINETECH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP FINETECH Ltd filed Critical ISP FINETECH Ltd
Publication of AU2002212659A1 publication Critical patent/AU2002212659A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002212659A 2000-10-24 2001-10-24 Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof Abandoned AU2002212659A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL13924300A IL139243A0 (en) 2000-10-24 2000-10-24 Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
IL139243 2000-10-24
PCT/IL2001/000982 WO2002038545A2 (en) 2000-10-24 2001-10-24 Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
AU2002212659A1 true AU2002212659A1 (en) 2002-05-21

Family

ID=11074754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212659A Abandoned AU2002212659A1 (en) 2000-10-24 2001-10-24 Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof

Country Status (4)

Country Link
US (1) US20040058901A1 (en)
AU (1) AU2002212659A1 (en)
IL (1) IL139243A0 (en)
WO (1) WO2002038545A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002251329A1 (en) * 2002-04-25 2003-11-10 Generics (Uk) Limited Novel crystalline forms of celecoxib and other compounds
US8933123B2 (en) 2010-10-08 2015-01-13 Cadila Healthcare Limited Polymorphic forms of O-desmethyl-venlafaxine succinate
US9603937B2 (en) 2015-03-09 2017-03-28 Theaprin Pharmaceuticals Inc. Platform drug delivery system utilizing crystal engineering and theanine dissolution
PT109030B (en) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. PREPARATION OF ZAFIRLUCAST INHALABLE PARTICULES
WO2018140858A1 (en) * 2017-01-30 2018-08-02 Western New England University Thiol isomerases inhibitors and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
WO2002038545A3 (en) 2002-07-25
US20040058901A1 (en) 2004-03-25
IL139243A0 (en) 2001-11-25
WO2002038545A2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
HUP0302519A3 (en) Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
HUP0300826A3 (en) Polymorphs of an epothilone analog, process for their preparation and pharmaceutical compositions containing them
HUP0400998A3 (en) Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them
HUP0401213A3 (en) Compounds effecting glucokinase, process for their preparation and their use for production of pharmaceutical compositions
PL347971A1 (en) Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
AU2002360473A1 (en) Method for preparation of three-demensional bodies
IL161693A0 (en) N-adamantylmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
AU2001295939A1 (en) Process for preparation of polyisocyanate composition
AU2002241793A1 (en) Process for the preparation of organoclays
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
AU2001258677A1 (en) Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them
AU2002218075A1 (en) Substituted bis-indole derivatives useful as contrast agents, pharmaceutical compositions containing them and intermediates for producing them
HUP0300389A3 (en) Crystalline form ii of cabergoline, process for its preparation and pharmaceutical compositions containing it
AU2002212659A1 (en) Crystalline ethanolate solvate form of zafirlukast, process for manufacture and pharmaceutical compositions thereof
AU2003282375A1 (en) Pharmaceutical compositions and process of production thereof
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU2002210816A1 (en) Process for preparation of beta-phenethylamine derivative
AU2003300018A1 (en) Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents
AU2002213477A1 (en) Process for preparation of n-substituted 2-sulfanylimidazoles
HUP0200643A3 (en) Dibenzoazulene derivatives, pharmaceutical compositions containing them, process for producing them and use of them for producing pharmaceutical compositions
AU2002240835A1 (en) Process for the manufacture of solid formulations
HUP0002147A2 (en) Process of ntc-2000 code-number for producing compounds having antiplasmid activity and pharmaceutical compositions containind them
AU2002222316A1 (en) Process for the preparation of zafirlukast